Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
May-2018 Volume 17 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2018 Volume 17 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Protection of Luteolin-7-O-glucoside against apoptosis induced by hypoxia/reoxygenation through the MAPK pathways in H9c2 cells

Retraction in: /10.3892/mmr.2025.13591
  • Authors:
    • Shenjie Chen
    • Bingsheng Yang
    • Yifei Xu
    • Yiqing Rong
    • Yuangang Qiu
  • View Affiliations / Copyright

    Affiliations: Department of Cardiology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310006, P.R. China
    Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 7156-7162
    |
    Published online on: March 19, 2018
       https://doi.org/10.3892/mmr.2018.8774
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Myocardial hypertrophy is often associated with myocardial infarction. Luteolin-7-O-glucoside (LUTG) has the prosperity of preventing cardiomyocyte injury. The current study aimed to explore the potential protective effect of LUTG and its relevant mechanisms in the heart. To establish the cardiac hypertrophy model in vitro, Angiotensin II (Ang II) was used to stimuli H9c2 cells in this study. The CCK‑8 assay showed that LUTG pretreatment improved cell viability of cardiomyocytes co‑treated with Ang II and ischemia/reperfusion. LUTG decreased the reactive oxygen species levels. Furthermore, it was demonstrated LUTG could reduce the release amount of lactate dehydrogenase and recover the catalase activity according to the flow cytometry analysis, and activity detection, respectively in Ang II‑H/R‑treated H9c2 cells. In addition, the flow cytometry analysis showed that the pretreatment of LUTG mitigated cell apoptosis induced by hypoxia/reoxygenation in the cardiac hypertrophy model. Meanwhile, reverse transcription‑quantitative polymerase chain reaction and western blot assays showed that the apoptosis‑related genes, including poly (ADP‑ribose) polymerase, Fas, Fasl and Caspase‑3 were downregulated at the transcriptional and translational levels. Notably, the protien expression of phosphorylated (p)‑extracellular signal‑regulated kinas (ERK) 1/2, p‑janus kinase and p‑P38 were reduced, while the expression of p‑ERK5 was elevated in the LUTG pretreatment groups compared with the hypoxia/reoxygenation treatment group. Based on these results, it was suggested that the anti‑apoptosis effect of LUTG may be associated with regulating the activation of mitogen‑activated protein kinases signaling pathways.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR and White HD: Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Katus HA, Lindahl B, Morrow DA, et al: Third universal definition of myocardial infarction. Circulation. 126:2020–2035. 2012. View Article : Google Scholar : PubMed/NCBI

2 

Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scalia R, Kiss L, Szabo C, et al: Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA. 104:pp. 15560–15565. 2007; View Article : Google Scholar : PubMed/NCBI

3 

Wang SQ, Han XZ, Li X, Ren DM, Wang XN and Lou HX: Flavonoids from Dracocephalum tanguticum and their cardioprotective effects against doxorubicin-induced toxicity in H9c2 cells. Bioorg Med Chem Lett. 20:6411–6415. 2010. View Article : Google Scholar : PubMed/NCBI

4 

Anversa P, Ricci R and Olivetti G: Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy: A review. J Am Coll Cardiol. 7:1140–1149. 1986. View Article : Google Scholar : PubMed/NCBI

5 

Fliss H and Gattinger D: Apoptosis in ischemic and reperfused rat myocardium. Circ Res. 79:949–956. 1996. View Article : Google Scholar : PubMed/NCBI

6 

Islam BU, Habib S, Ahmad P, Allarakha S, Moinuddin and Ali A: Pathophysiological role of peroxynitrite induced DNA damage in human diseases: A special focus on poly (ADP-ribose) polymerase (PARP). Indian J Clin Biochem. 30:368–385. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Gonzalez-Cuadrado S, Lorz C, Garcia del Moral R, O'Valle F, Alonso C, Ramiro F, Ortiz-Gonzalez A, Egido J and Ortiz A: Agonistic anti-Fas antibodies induce glomerular cell apoptosis in mice in vivo. Kidney Int. 51:1739–1746. 1997. View Article : Google Scholar : PubMed/NCBI

8 

Gonzalez-Cuadrado S, Lopez-Armada MJ, Gomez-Guerrero C, Subira D, Garcia-Sahuquillo A, Ortiz-Gonzalez A, Neilson EG, Egido J and Ortiz A: Anti-Fas antibodies induce cytolysis and apoptosis in cultured human mesangial cells. Kidney Int. 49:1064–1070. 1996. View Article : Google Scholar : PubMed/NCBI

9 

Dolka I, Krol M and Sapierzynski R: Evaluation of apoptosis-associated protein (Bcl-2, Bax, cleaved caspase-3 and p53) expression in canine mammary tumors: An immunohistochemical and prognostic study. Res Vet Sci. 105:124–133. 2016. View Article : Google Scholar : PubMed/NCBI

10 

Lu F, Xing J, Zhang X, Dong S, Zhao Y, Wang L, Li H, Yang F, Xu C and Zhang W: Exogenous hydrogen sulfide prevents cardiomyocyte apoptosis from cardiac hypertrophy induced by isoproterenol. Mol Cell Biochem. 381:41–50. 2013. View Article : Google Scholar : PubMed/NCBI

11 

Santin Y, Sicard P, Vigneron F, Guilbeau-Frugier C, Dutaur M, Lairez O, Couderc B, Manni D, Korolchuk VI, Lezoualc'h F, et al: Oxidative stress by monoamine oxidase-A impairs transcription factor EB activation and autophagosome clearance, leading to cardiomyocyte necrosis and heart failure. Antioxid Redox Signal. 25:10–27. 2016. View Article : Google Scholar : PubMed/NCBI

12 

Zhang RQ, Li DY, Xu TD, Zhu SS, Pan HJ, Fang F, Wu X and Sun H: Antioxidative effect of luteolin pretreatment on simulated ischemia/reperfusion injury in cardiomyocyte and perfused rat heart. Chin J Integr Med. 23:518–527. 2017. View Article : Google Scholar : PubMed/NCBI

13 

Jagadeesh GS, Nagoor Meeran MF and Selvaraj P: Activation of beta1-adrenoceptor triggers oxidative stress mediated myocardial membrane destabilization in isoproterenol induced myocardial infarcted rats: 7-hydroxycoumarin and its counter action. Eur J Pharmacol. 777:70–77. 2016. View Article : Google Scholar : PubMed/NCBI

14 

Lin Y, Shi R, Wang X and Shen HM: Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets. 8:634–646. 2008. View Article : Google Scholar : PubMed/NCBI

15 

Lee HZ, Yang WH, Bao BY and Lo PL: Proteomic analysis reveals ATP-dependent steps and chaperones involvement in luteolin-induced lung cancer CH27 cell apoptosis. Eur J Pharmacol. 642:19–27. 2010. View Article : Google Scholar : PubMed/NCBI

16 

Wolfle U, Esser PR, Simon-Haarhaus B, Martin SF, Lademann J and Schempp CM: UVB-induced DNA damage, generation of reactive oxygen species, and inflammation are effectively attenuated by the flavonoid luteolin in vitro and in vivo. Free Radic Biol Med. 50:1081–1093. 2011. View Article : Google Scholar : PubMed/NCBI

17 

Chen CY, Peng WH, Tsai KD and Hsu SL: Luteolin suppresses inflammation-associated gene expression by blocking NF-kappaB and AP-1 activation pathway in mouse alveolar macrophages. Life Sci. 81:1602–1614. 2007. View Article : Google Scholar : PubMed/NCBI

18 

Chen HQ, Jin ZY, Wang XJ, Xu XM, Deng L and Zhao JW: Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation. Neurosci Lett. 448:175–179. 2008. View Article : Google Scholar : PubMed/NCBI

19 

Martin H, Flandez M, Nombela C and Molina M: Protein phosphatases in MAPK signalling: We keep learning from yeast. Mol Microbiol. 58:6–16. 2005. View Article : Google Scholar : PubMed/NCBI

20 

Gerits N, Kostenko S and Moens U: In vivo functions of mitogen-activated protein kinases: Conclusions from knock-in and knock-out mice. Transgenic Res. 16:281–314. 2007. View Article : Google Scholar : PubMed/NCBI

21 

Baines CP and Molkentin JD: STRESS signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol. 38:47–62. 2005. View Article : Google Scholar : PubMed/NCBI

22 

Petrich BG and Wang Y: Stress-activated MAP kinases in cardiac remodeling and heart failure; new insights from transgenic studies. Trends Cardiovasc Med. 14:50–55. 2004. View Article : Google Scholar : PubMed/NCBI

23 

Frey N, Katus HA, Olson EN and Hill JA: Hypertrophy of the heart: A new therapeutic target? Circulation. 109:1580–1589. 2004. View Article : Google Scholar : PubMed/NCBI

24 

Mutlak M and Kehat I: Extracellular signal-regulated kinases 1/2 as regulators of cardiac hypertrophy. Front Pharmacol. 6:1492015. View Article : Google Scholar : PubMed/NCBI

25 

Al-Rasheed NM, Al-Oteibi MM, Al-Manee RZ, Al-Shareef SA, Al-Rasheed NM, Hasan IH, Mohamad RA and Mahmoud AM: Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway. Drug Des Devel Ther. 9:3217–3229. 2015.PubMed/NCBI

26 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

27 

Yao H, Shang Z, Wang P, Li S, Zhang Q, Tian H, Ren D and Han X: Protection of Luteolin-7-O-Glucoside against doxorubicin-induced injury through PTEN/Akt and ERK pathway in H9c2 cells. Cardiovasc Toxicol. 16:101–110. 2016. View Article : Google Scholar : PubMed/NCBI

28 

Palombo R, Savini I, Avigliano L, Madonna S, Cavani A, Albanesi C, Mauriello A, Melino G and Terrinoni A: Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model. Cell Death Dis. 7:e23442016. View Article : Google Scholar : PubMed/NCBI

29 

Zhao Y, Hu X, Liu Y, Dong S, Wen Z, He W, Zhang S, Huang Q and Shi M: ROS signaling under metabolic stress: Cross-talk between AMPK and AKT pathway. Mol Cancer. 16:792017. View Article : Google Scholar : PubMed/NCBI

30 

Han XZ, Gao S, Cheng YN, Sun YZ, Liu W, Tang LL and Ren DM: Protective effect of naringenin-7-O-glucoside against oxidative stress induced by doxorubicin in H9c2 cardiomyocytes. Biosci Trends. 6:19–25. 2012.PubMed/NCBI

31 

Kirsch R and Kampf G: On the catlase activity in rat Walker carcinoma. The effect of endoxan on enzymatic activity. Arch Geschwulstforsch. 26:234–237. 1965.PubMed/NCBI

32 

Bround MJ, Wambolt R, Luciani DS, Kulpa JE, Rodrigues B, Brownsey RW, Allard MF and Johnson JD: Cardiomyocyte ATP production, metabolic flexibility, and survival require calcium flux through cardiac ryanodine receptors in vivo. J Biol Chem. 288:18975–18986. 2013. View Article : Google Scholar : PubMed/NCBI

33 

Sun Y, Ye L, Jiang C, Jiang J, Hong H and Qiu L: Over-expression of HSPA12B protects mice against myocardium ischemic/reperfusion injury through a PPARgamma-dependent PI3K/Akt/eNOS pathway. Am J Transl Res. 7:2724–2737. 2015.PubMed/NCBI

34 

Ozaki T, Yamashita T and Ishiguro S: Mitochondrial m-calpain plays a role in the release of truncated apoptosis-inducing factor from the mitochondria. Biochim Biophys Acta. 1793:1848–1859. 2009. View Article : Google Scholar : PubMed/NCBI

35 

Filippone EJ and Foy AJ: Blood pressure management in the wake of SPRINT. Cleve Clin J Med. 83:196–198. 2016. View Article : Google Scholar : PubMed/NCBI

36 

Shao M, Zhuo C, Jiang R, Chen G, Shan J, Ping J, Tian H, Wang L, Lin C and Hu L: Protective effect of hydrogen sulphide against myocardial hypertrophy in mice. Oncotarget. 8:22344–22352. 2017. View Article : Google Scholar : PubMed/NCBI

37 

Cave A, Grieve D, Johar S, Zhang M and Shah AM: NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology. Philos Trans R Soc Lond B Biol Sci. 360:2327–2334. 2005. View Article : Google Scholar : PubMed/NCBI

38 

Li JM, Gall NP, Grieve DJ, Chen M and Shah AM: Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension. 40:477–484. 2002. View Article : Google Scholar : PubMed/NCBI

39 

Ko WG, Kang TH, Lee SJ, Kim YC and Lee BH: Effects of luteolin on the inhibition of proliferation and induction of apoptosis in human myeloid leukaemia cells. Phytother Res. 16:295–298. 2002. View Article : Google Scholar : PubMed/NCBI

40 

Chen P, Zhang JY, Sha BB, Ma YE, Hu T, Ma YC, Sun H, Shi JX, Dong ZM and Li P: Luteolin inhibits cell proliferation and induces cell apoptosis via down-regulation of mitochondrial membrane potential in esophageal carcinoma cells EC1 and KYSE450. Oncotarget. 8:27471–27480. 2017.PubMed/NCBI

41 

Kang JH, Lee HS, Park D, Kang YW, Kim SM, Gong JR and Cho KH: Context-independent essential regulatory interactions for apoptosis and hypertrophy in the cardiac signaling network. Sci Rep. 7:342017. View Article : Google Scholar : PubMed/NCBI

42 

Wang Y: Mitogen-activated protein kinases in heart development and diseases. Circulation. 116:1413–1423. 2007. View Article : Google Scholar : PubMed/NCBI

43 

Sun J, Sun G, Meng X, Wang H, Luo Y, Qin M, Ma B, Wang M, Cai D, Guo P, et al: Isorhamnetin protects against doxorubicin-induced cardiotoxicity in vivo and in vitro. PloS One. 8:e645262013. View Article : Google Scholar : PubMed/NCBI

44 

Miller WP, Ravi S, Martin TD, Kimball SR and Dennis MD: Activation of the stress response kinase JNK (c-Jun N-terminal kinase) attenuates insulin action in retina through a p70S6K1-dependent mechanism. J Biol Chem. 292:1591–1602. 2017. View Article : Google Scholar : PubMed/NCBI

45 

Lorenzon A, Calore M, Poloni G, De Windt LJ, Braghetta P and Rampazzo A: Wnt/beta-catenin pathway in arrhythmogenic cardiomyopathy. Oncotarget. 8:60640–60655. 2017. View Article : Google Scholar : PubMed/NCBI

46 

Muthusamy VR, Kannan S, Sadhaasivam K, Gounder SS, Davidson CJ, Boeheme C, Hoidal JR, Wang L and Rajasekaran NS: Acute exercise stress activates Nrf2/ARE signaling and promotes antioxidant mechanisms in the myocardium. Free Radic Biol Med. 52:366–376. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chen S, Yang B, Xu Y, Rong Y and Qiu Y: Protection of Luteolin-7-O-glucoside against apoptosis induced by hypoxia/reoxygenation through the MAPK pathways in H9c2 cells Retraction in /10.3892/mmr.2025.13591. Mol Med Rep 17: 7156-7162, 2018.
APA
Chen, S., Yang, B., Xu, Y., Rong, Y., & Qiu, Y. (2018). Protection of Luteolin-7-O-glucoside against apoptosis induced by hypoxia/reoxygenation through the MAPK pathways in H9c2 cells Retraction in /10.3892/mmr.2025.13591. Molecular Medicine Reports, 17, 7156-7162. https://doi.org/10.3892/mmr.2018.8774
MLA
Chen, S., Yang, B., Xu, Y., Rong, Y., Qiu, Y."Protection of Luteolin-7-O-glucoside against apoptosis induced by hypoxia/reoxygenation through the MAPK pathways in H9c2 cells Retraction in /10.3892/mmr.2025.13591". Molecular Medicine Reports 17.5 (2018): 7156-7162.
Chicago
Chen, S., Yang, B., Xu, Y., Rong, Y., Qiu, Y."Protection of Luteolin-7-O-glucoside against apoptosis induced by hypoxia/reoxygenation through the MAPK pathways in H9c2 cells Retraction in /10.3892/mmr.2025.13591". Molecular Medicine Reports 17, no. 5 (2018): 7156-7162. https://doi.org/10.3892/mmr.2018.8774
Copy and paste a formatted citation
x
Spandidos Publications style
Chen S, Yang B, Xu Y, Rong Y and Qiu Y: Protection of Luteolin-7-O-glucoside against apoptosis induced by hypoxia/reoxygenation through the MAPK pathways in H9c2 cells Retraction in /10.3892/mmr.2025.13591. Mol Med Rep 17: 7156-7162, 2018.
APA
Chen, S., Yang, B., Xu, Y., Rong, Y., & Qiu, Y. (2018). Protection of Luteolin-7-O-glucoside against apoptosis induced by hypoxia/reoxygenation through the MAPK pathways in H9c2 cells Retraction in /10.3892/mmr.2025.13591. Molecular Medicine Reports, 17, 7156-7162. https://doi.org/10.3892/mmr.2018.8774
MLA
Chen, S., Yang, B., Xu, Y., Rong, Y., Qiu, Y."Protection of Luteolin-7-O-glucoside against apoptosis induced by hypoxia/reoxygenation through the MAPK pathways in H9c2 cells Retraction in /10.3892/mmr.2025.13591". Molecular Medicine Reports 17.5 (2018): 7156-7162.
Chicago
Chen, S., Yang, B., Xu, Y., Rong, Y., Qiu, Y."Protection of Luteolin-7-O-glucoside against apoptosis induced by hypoxia/reoxygenation through the MAPK pathways in H9c2 cells Retraction in /10.3892/mmr.2025.13591". Molecular Medicine Reports 17, no. 5 (2018): 7156-7162. https://doi.org/10.3892/mmr.2018.8774
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team